VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
RNAAtrium Therapeutics, Inc.
$12.75$218M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksRNAPrice History

RNA logoAtrium Therapeutics, Inc. (RNA) Stock Price History

Historical prices from 2020 to 2026

$12.75+0.38  (+3.07%)close Jun 15
Returns
1M
-3.6%
3M
-7.5%
YTD
-82.3%
1Y
-57.2%
3Y
+0.7%
5Y
-13.5%
ATH$73.06Feb 2026-82.5%
ATL$4.83Oct 2023pre-split
Avg Vol (50D)246K/ day
52-Week Range$11.40 — $73.06
LowCurrent: $12.75High

Loading 10-year price history...

RNA Historical Performance

1 YearTotal Return
-57.2%
Price: -57.2%
3 YearsTotal Return
+2.2%
CAGR: +0.7%
Price: +2.2%
5 YearsTotal Return
-51.5%
CAGR: -13.5%
Price: -51.5%
YTD
-82.3%

RNA Annual Returns

Year-by-year price performance · 2020–2026

Best+217.5%2024
Worst-55.3%2023
Up years2/7
2020-10.5%
2021-6.7%
2022-6.7%
2023-55.3%
2024+217.5%
2025+131.3%
2026-79.5%
2020 annual price return
-10.5%
2021 annual price return
-6.7%
2022 annual price return
-6.7%
2023 annual price return
-55.3%
2024 annual price return
+217.5%
2025 annual price return
+131.3%
2026 annual price return
-79.5%
LessMore
Alpha vs S&P 500
1Y-82.5%
3Y-17.6%
5Y-26.0%

Price returns only.

Download Historical Data

1,509 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

RNA Stock Price Trajectory (2020–2026)

As of June 16, 2026, Atrium Therapeutics, Inc. (RNA) trades at $12.75, representing a -57.2% return over the past year. The stock has delivered a -51.5% total return over five years (-13.5% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $73.06 on February 3, 2026. From this peak, RNA has corrected -82.5%, currently trading 71% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers SRPT (-24.7% 1Y), MDWD (-31.9% 1Y), and FOLD (+139.5% 1Y), RNA has underperformed the peer group average. Compare RNA vs SRPT →

RNA Historical Price Data · from 2020

Rows 1–50 of 1,509
Date Open High Low Close Volume Change %
2026-06-1512.4012.7612.3112.7556K+3.07%
2026-06-1212.4312.4612.1612.37104K-0.48%
2026-06-1111.6912.5311.4012.43271K+6.51%
2026-06-1011.8611.9811.6611.67137K-0.77%
2026-06-0911.6011.8911.4511.76200K+1.82%
2026-06-0811.9011.9011.4811.55124K-2.12%
2026-06-0512.3012.3011.7711.80209K-4.07%
2026-06-0412.2612.5812.2612.30126K+1.07%
2026-06-0312.2712.3912.1212.17148K-0.65%
2026-06-0212.5912.5912.2012.25169K-3.39%
2026-06-0113.0013.0012.3512.68205K-2.46%
2026-05-2913.2713.6012.9413.00316K-2.69%
2026-05-2813.1014.1312.9813.36345K+2.77%
2026-05-2713.0813.1212.9313.00167K-0.46%
2026-05-2613.2013.2812.9613.06154K-0.23%
2026-05-2213.0113.1012.9813.09292K+0.38%
2026-05-2112.6113.1312.6113.04250K+2.52%
2026-05-2012.9413.0112.6112.72162K-1.78%
2026-05-1912.9613.2012.7712.95273K0.00%
2026-05-1813.2413.5612.8512.95147K-2.12%
2026-05-1513.4813.9713.0413.23224K-0.30%
2026-05-1413.2713.5113.1013.2799K-0.23%
2026-05-1313.1113.3012.9113.30100K+1.22%
2026-05-1213.3413.4013.0713.14170K-0.83%
2026-05-1113.0813.4613.0713.25160K+1.38%
2026-05-0812.8813.1912.8813.07102K+0.85%
2026-05-0713.0713.2012.8112.9674K-0.99%
2026-05-0612.9413.3012.8013.09178K+1.39%
2026-05-0512.8613.0312.7512.91103K+0.31%
2026-05-0413.3013.5712.8112.87141K-4.17%
2026-05-0112.7613.4912.7613.43169K+5.17%
2026-04-3013.0013.4912.7112.77249K-1.69%
2026-04-2912.5013.0612.5012.99162K+3.51%
2026-04-2813.0013.0012.5112.55194K-2.71%
2026-04-2713.5913.6612.7912.90284K-4.37%
2026-04-2413.7813.7813.4613.49183K-2.60%
2026-04-2314.0114.8013.6813.85492K+1.39%
2026-04-2213.6513.9213.5013.66547K+0.96%
2026-04-2114.2414.2513.5013.53238K-5.38%
2026-04-2014.4214.5014.2014.30547K-0.76%
2026-04-1713.9814.6313.9814.41633K+2.71%
2026-04-1614.4614.5113.8814.03274K-3.51%
2026-04-1514.0014.5913.9214.54567K+3.71%
2026-04-1413.3014.0513.1814.02366K+5.41%
2026-04-1312.6713.3112.6613.30279K+4.64%
2026-04-1013.6413.7912.6312.711.02M-7.36%
2026-04-0913.7113.9313.6013.72218K+0.15%
2026-04-0814.0014.1813.5413.70192K-2.07%
2026-04-0713.7014.0013.5513.99234K+2.34%
2026-04-0613.4413.9213.4413.67172K+1.71%
…

What if you invested $1,000 in RNA 10 years ago?

Total return calculator · dividends reinvested

Calculate Returns

How much would $100/month in RNA be worth today?

Dollar cost averaging vs lump sum · see how regular investing compounds over time

Run the Numbers

Is RNA Undervalued Right Now?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

RNA vs LLY — which is the better buy?

Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.

Compare Now

RNA — Frequently Asked Questions

Quick answers to the most common questions about buying RNA stock.

How has RNA stock performed recently?

RNA declined -57.2% over the past year, below its 5-year annualized CAGR of -13.5%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is RNA's all-time high price?

Atrium Therapeutics, Inc. reached $73.06 on 2026-02-03. The 52-week high is $73.06. Current 1-year return of -57.2% places the stock further from historical peaks.

Where can I download RNA historical price data?

This page provides RNA daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2020-2026, downloadable in CSV format.

378 data points · sampled from 1,509